New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Flora Growth Corp.
FLGC
Shape
US Flag

NASDAQ

25M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

25M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

1.84USD
Shape-0.14 ( -7.07%)
Market Open
favorite-chart

Relative Strenght

18
favorite-chart

Volume Buzz

45%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

37%

Quote Panel

Shape
Updated October 29, 2024
1W 8.24 % 1M 20.26 % 3M 75.24 % 1Y 150.68 %

Key Metrics

Shape
  • Market Cap

    24.59M


  • Shares Outstanding

    13.37M


  • Share in Float

    9.33M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    1.84


  • Average Volume

    196767


  • Beta

    1.861


  • Range

    0.7-2.929


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.floragrowth.com


  • Sector

    Healthcare


Fundamentals

Shape

0.75x

P/E Ratio

0.36x

P/S Ratio

3.09x

P/B Ratio

0.8

Debt/Equity

-18.9%

Net Margin

$-0.9

EPS

How FLGC compares to sector?

P/E Ratio

Relative Strength

Shape

FLGC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$78M

Shape395%

2025-Revenue

$0.34

Shape262%

2025-EPS

$14M

Shape-449%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Alliance Global Partners

downgrade

Previous: Buy

2024-08-15

Now: Neutral

Cantor Fitzgerald

initialise

Previous: Not converted

2022-08-08

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.40
vs -1.63

Q4.22

arrow
arrow

N/A

-3.00
vs -4.79

Q1.23

arrow
arrow

N/A

-0.60
vs -2.16

Q2.23

arrow
arrow

N/A

-0.31
vs -11.23

Q3.23

arrow
arrow

N/A

-0.05
vs -1.40

Q4.23

arrow
arrow

+200%

3
vs -3.00

Q1.24

arrow
arrow

N/A

-0.28
vs -0.60

Q2.24

arrow
arrow

N/A

-0.22
vs -0.31

Q3.24

arrow
arrow

N/A

-0.09
vs -0.05

Q4.24

arrow
arrow

N/A

-0.03
vs 3

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+414%

10.8M  vs 2.1M

Q4.22

arrow
arrow

+141%

11.5M  vs 4.8M

Q1.23

arrow
arrow

+307%

20.1M  vs 4.9M

Q2.23

arrow
arrow

+115%

21.5M  vs 10M

Q3.23

arrow
arrow

+61%

17.3M  vs 10.8M

Q4.23

arrow
arrow

+56%

18M  vs 11.5M

Q1.24

arrow
arrow

-10%

18M  vs 20.1M

Q2.24

arrow
arrow

-27%

15.7M  vs 21.5M

Q3.24

arrow
arrow

-3%

16.8M  vs 17.3M

Q4.24

arrow
arrow

-1%

17.8M  vs 18M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-14%

-0.14
vs -0.69

Q4.22

arrow
arrow

-22%

-0.22
vs -0.14

Q1.23

arrow
arrow

-7%

-0.07
vs -0.22

Q2.23

arrow
arrow

-407%

-4.07
vs -0.07

Q3.23

arrow
arrow

+9%

0.09
vs -4.07

Q4.23

arrow
arrow

-129%

-1.29
vs 0.09

Q1.24

arrow
arrow

-108%

-1.08
vs -1.29

Q2.24

arrow
arrow

-36%

-0.36
vs -1.08

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

30

30
vs 35

-14%

Q4.22

arrow
arrow

39

39
vs 30

30%

Q1.23

arrow
arrow

33

33
vs 39

-15%

Q2.23

arrow
arrow

2

2
vs 33

-94%

Q3.23

arrow
arrow

1

1
vs 2

-50%

Q4.23

arrow
arrow

4

4
vs 1

300%

Q1.24

arrow
arrow

4

4
vs 4

NA

Q2.24

arrow
arrow

3

3
vs 4

-25%

Earnings Growth

Latest News